{"DataElement":{"publicId":"3915853","version":"1.1","preferredName":"Surgical Margin Neoplasm Distance Measurement","preferredDefinition":"Numeric value for the distance between a malignant neoplasm and a surgical margin, the edge or border of the tissue removed in surgery.","longName":"SURG_MARG_NEO_DIS_UOM","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3915846","version":"1","preferredName":"Surgical Margin Neoplasm Distance","preferredDefinition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The space between two objects or points.","longName":"2427288v1.0:3915844v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2427288","version":"1","preferredName":"Surgical Margin","preferredDefinition":"The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.","longName":"C41227","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EAE3-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-08","endDate":null,"createdBy":"PWEST","dateCreated":"2005-11-08","modifiedBy":"ONEDATA","dateModified":"2005-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3915844","version":"1","preferredName":"Neoplasm Distance","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The space between two objects or points.","longName":"C3262:C25167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Distance","conceptCode":"C25167","definition":"The space separating two objects or points.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E83FFABA-2334-AA84-E040-BB89AD430656","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-08","modifiedBy":"ONEDATA","dateModified":"2013-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008574","version":"1","preferredName":"Surgical Margin Measurements","preferredDefinition":"any measurements of a patient's surgical margins.","longName":"SURG_MARG_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB880E47-7AFF-254C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E83FFABA-2345-AA84-E040-BB89AD430656","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-08","modifiedBy":"TAYLORT","dateModified":"2017-08-07","changeDescription":"8/7/17 tt transferred context and added registration status, CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3915850","version":"1","preferredName":"Surgical Margin Tumor Distance Measurement","preferredDefinition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"3915850v1.0","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008574","version":"1","preferredName":"Surgical Margin Measurements","preferredDefinition":"any measurements of a patient's surgical margins.","longName":"SURG_MARG_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB880E47-7AFF-254C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184312","version":"1","preferredName":"Measurement","preferredDefinition":"Measurement; the size or magnitude of something.","longName":"C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DB6C8AC6-1DB1-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2006-10-26","changeDescription":"Move to caBIG context as teh preferred Rep class for Measurement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E8408410-0D1C-46E3-E040-BB89AD434E06","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-08","modifiedBy":"TAYLORT","dateModified":"2017-08-07","changeDescription":"8/7/17 tt transferred context and added registration status, CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3914492","version":"1","longName":"Diagnosis Gross Tumor CRF","context":"NCIP"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5915896","version":"1","longName":"Gross Pathology","context":"NCI Standards"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000454","version":"1","longName":"Head and Neck","context":"OCG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"3915846v1.0:3915850v1.0","type":"System-Generated","context":"NCI Standards"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Margin distance","type":"Preferred Question Text","description":"Margin distance","url":null,"context":"NCI Standards"},{"name":"Margin distance (mm)","type":"Alternate Question Text","description":"Margin distance (mm)","url":null,"context":"OCG"},{"name":"Distance of small cell malignancy from closest margin? (mm)","type":"Alternate Question Text","description":"Distance of small cell malignancy from closest margin? (mm)","url":null,"context":"COG"},{"name":"Distance of rhabdomyoblasts from closest margin? (mm)","type":"Alternate Question Text","description":"Distance of rhabdomyoblasts from closest margin? (mm)","url":null,"context":"COG"},{"name":"Distance of poorly differentiated malignancy  from closest margin? (mm)","type":"Alternate Question Text","description":"Distance of poorly differentiated malignancy  from closest margin? (mm)","url":null,"context":"COG"},{"name":"COG Text 1","type":"Alternate Question Text","description":"Distance of differentiated rhabdomyoblasts from closest margin? (mm)","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"562C2B85-1BB8-1BC0-E053-F662850AF5E5","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-07","modifiedBy":"GDEEN","dateModified":"2022-06-03","changeDescription":"8/22/17 tt released CDE.  8/7/17 tt CDE versioned for short name change; transferred Context, changed reg status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}